{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:09:27Z","timestamp":1790690967649,"version":"4.1.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.eplepsyres.2026.107859","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:23:18Z","timestamp":1782343398000},"page":"107859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Letter to the editor: A critical appraisal of 'principal component analysis of antiseizure medication-induced hostility\/aggression and factor analysis of levetiracetam"],"prefix":"10.1016","author":[{"given":"Parth","family":"Aphale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Shekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashank","family":"Dokania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.eplepsyres.2026.107859_bib1","first-page":"985","article-title":"Behavioral side-effects of levetiracetam in children with epilepsy: a systematic review","volume":"23","author":"Halma","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2026.107859_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2025.107626","article-title":"Principal component analysis of antiseizure medication-induced hostility\/aggression and factor analysis of levetiracetam using the food and drug administration adverse event reporting system","volume":"218","author":"Hosoya","year":"2025","journal-title":"Epilepsy Res."},{"issue":"10","key":"10.1016\/j.eplepsyres.2026.107859_bib3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/BF03261981","article-title":"Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France","volume":"35","author":"Pariente","year":"2012","journal-title":"Drug. Saf."},{"issue":"4","key":"10.1016\/j.eplepsyres.2026.107859_bib4","first-page":"195","article-title":"The use of propensity scores in pharmacoepidemiology","volume":"13","author":"Sturmer","year":"2004","journal-title":"Pharmacoepidemiol. Drug. Saf."},{"issue":"2","key":"10.1016\/j.eplepsyres.2026.107859_bib5","first-page":"207","article-title":"The case-crossover design: an overview","volume":"20","author":"Suissa","year":"2011","journal-title":"Pharmacoepidemiol. Drug. Saf."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121126001294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121126001294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:50:48Z","timestamp":1790689848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121126001294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":5,"alternative-id":["S0920121126001294"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2026.107859","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Letter to the editor: A critical appraisal of 'principal component analysis of antiseizure medication-induced hostility\/aggression and factor analysis of levetiracetam","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2026.107859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107859"}}